# UCLA Medical IRB 1 (OHRPP) – FDA Inspection, Jun 26, 2019

Source: https://www.keypedia.com/records/fda_inspections/ucla-medical-irb-1-ohrpp/be1f6cc8-cd70-476f-994d-5365b9bffb0b
Source feed: FDA_Inspections

> FDA inspection 1094207 of UCLA Medical IRB 1 (OHRPP), June 26, 2019. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 56. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1094207
- Company Name: UCLA Medical IRB 1 (OHRPP)
- Inspection Date: 2019-06-26
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1273458 - 2025-06-04
- FDA Inspection 814083 - 2012-12-10

## Related Officers

- [Company Rep](https://www.keypedia.com/people/humberto-z-gomez/6de682f6-ae2a-45ff-92ab-ba6ac7bb97b4)

Company: https://www.keypedia.com/companies/ucla-medical-irb-1-ohrpp/fc6e5ea2-217f-4200-b293-eaa3b8d8a96f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
